A mortality review of tuberculosis and HIV co-infected patients in Mahalapye, Botswana: Does cotrimoxazole preventive therapy and/or antiretroviral therapy protect against death?

Background: The World Health Organization aims to reduce tuberculosis (TB) mortality rate from 15% in 2015 to 6.5% by 2025. Aim: This study determined the profile of TB and human immunodeficiency virus (HIV) co-infected patients who died in Mahalapye District, Botswana, while on anti-TB medication...

Full description

Bibliographic Details

Published in:	African Journal of Primary Health Care & Family Medicine
Main Authors:	Stephane Tshitenge, Gboyega A. Ogunbanjo, Andre Citeya
Format:	Article
Language:	English
Published:	AOSIS 2018-11-01
Subjects:	tuberculosis mortality anti-tuberculosis cotrimoxazole-prevention-therapy antiretroviral
Online Access:	https://phcfm.org/index.php/phcfm/article/view/1765